- Supported exchanges /
- SHE /
- 301277.SHE
Henan Newland Pharmaceutical Co. Ltd. A (301277 SHE) stock market data APIs
Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers intermediates, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil, chlorpheniramine maleate, clopidogrel bisulfate, lidocaine, febuxostat, esomeprazole sodium, and esomeprazole magnesium. The company was formerly known as Henan Newland Pharmaceutical Co., Ltd. and changed its name to Newland Pharmaceutical Co., Ltd. in June 2023. Newland Pharmaceutical Co., Ltd. was founded in 2005 and is based in Changge City, China.
Henan Newland Pharmaceutical Co. Ltd. A Financial Data Overview
| 14.63 | |
| 14.35 | |
| - | |
| 14.63 | |
| 14.3 | |
| 9.0738-18.38 | |
| 4 005 M | |
| 24.6552 | |
| 280 M | |
| 699 M | |
| 0.1082 | |
| 0.028 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Henan Newland Pharmaceutical Co. Ltd. A Fundamental Data is available in our Financial Data APIs
- Net Revenue 699 M
- EBITDA 210 M
- Earnings Per Share 0.58
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Henan Newland Pharmaceutical Co. Ltd. A Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Henan Newland Pharmaceutical Co. Ltd. A End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
